News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medical Compression Systems Ltd. Research: Landmark Head-to-Head S.A.F.E. Study Comparing ActiveCare+S.F.T. to Lovenox Published in Journal of Bone & Joint Surgery


3/1/2010 2:13:38 PM

OR AKIVA, Israel & WEST HILLS, Calif.--(BUSINESS WIRE)--Medical Compression Systems, Ltd. (TASE: MDCL), a company specializing in innovative non-invasive blood circulation solutions, today announced publication of the results from the landmark head-to-head S.A.F.E. (S.F.T. Alternative to Enoxaparin) study. The results, published as the lead article in the March 2010 issue of Journal of Bone and Joint Surgery, demonstrated that the ActiveCare+S.F.T® non-invasive mobile compression system, used as monotherapy, achieved no significant difference in efficacy and a significant decrease in major bleeding events compared to Lovenox® (enoxaparin sodium injection) in the prevention of venous thromboembolism (VTE) in total hip arthroplasty (THA).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES